These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34746460)

  • 21. A study of Mycobacterium tuberculosis genotypic diversity & drug resistance mutations in Varanasi, north India.
    Gupta A; Kulkarni S; Rastogi N; Anupurba S
    Indian J Med Res; 2014 Jun; 139(6):892-902. PubMed ID: 25109724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The burden of drug resistance tuberculosis in Ghana; results of the First National Survey.
    Sylverken AA; Kwarteng A; Twumasi-Ankrah S; Owusu M; Arthur RA; Dumevi RM; Adu-Amoah L; Addofoh N; Okyere PB; Dzata F; Bonsu F; Adusi-Poku Y; Kranzer K; Siroka A; Gemert WV; Dean A; Owusu-Dabo E
    PLoS One; 2021; 16(6):e0252819. PubMed ID: 34111159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatio-Temporal Distribution of Mycobacterium tuberculosis Complex Strains in Ghana.
    Yeboah-Manu D; Asare P; Asante-Poku A; Otchere ID; Osei-Wusu S; Danso E; Forson A; Koram KA; Gagneux S
    PLoS One; 2016; 11(8):e0161892. PubMed ID: 27564240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of
    Elegail A; Ibrahim Mohamed NY; Mohamed Nour EO; Hoffner S; Haile M
    Int J Mycobacteriol; 2018; 7(3):236-241. PubMed ID: 30198502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology of tuberculosis in Sicily, Italy: what has changed after a decade?
    Bonura C; Gomgnimbou MK; Refrégier G; Aleo A; Fasciana T; Giammanco A; Sola C; Mammina C
    BMC Infect Dis; 2014 Nov; 14():602. PubMed ID: 25407589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotyping and molecular detection of multidrug-resistant
    Zewdie O; Mihret A; Abebe T; Kebede A; Desta K; Worku A; Ameni G
    New Microbes New Infect; 2018 Jan; 21():36-41. PubMed ID: 29675262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Analysis of
    Pokam BDT; Yeboah-Manu D; Lawson L; Guemdjom PW; Okonu R; Madukaji L; Yhiler NY; Asuquo AE
    J Epidemiol Glob Health; 2019 Dec; 9(4):259-265. PubMed ID: 31854167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
    Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
    BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of Mycobacterium tuberculosis complex lineages and their role in an emerging threat of multidrug resistant tuberculosis in Bamako, Mali.
    Senghore M; Diarra B; Gehre F; Otu J; Worwui A; Muhammad AK; Kwambana-Adams B; Kay GL; Sanogo M; Baya B; Orsega S; Doumbia S; Diallo S; de Jong BC; Pallen MJ; Antonio M
    Sci Rep; 2020 Jan; 10(1):327. PubMed ID: 31941887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of spoligotyping defined genotypic lineages among drug-resistant Mycobacterium tuberculosis complex clinical isolates in Ankara, Turkey.
    Kisa O; Tarhan G; Gunal S; Albay A; Durmaz R; Saribas Z; Zozio T; Alp A; Ceyhan I; Tombak A; Rastogi N
    PLoS One; 2012; 7(1):e30331. PubMed ID: 22279583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular epidemiological study of multidrug-resistant tuberculosis isolated from sputum samples in Eastern Cape, South Africa.
    Bhembe NL; Green E
    Infect Genet Evol; 2020 Jun; 80():104182. PubMed ID: 31923728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.
    Ahmad S; Mokaddas E; Al-Mutairi N; Eldeen HS; Mohammadi S
    PLoS One; 2016; 11(4):e0153563. PubMed ID: 27096759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
    Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
    Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
    Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
    Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and characterization of drug-resistant conferring genes in Mycobacterium tuberculosis complex strains: A prospective study in two distant regions of Ghana.
    Otchere ID; Asante-Poku A; Osei-Wusu S; Baddoo A; Sarpong E; Ganiyu AH; Aboagye SY; Forson A; Bonsu F; Yahayah AI; Koram K; Gagneux S; Yeboah-Manu D
    Tuberculosis (Edinb); 2016 Jul; 99():147-154. PubMed ID: 27450017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana.
    Addo KK; Addo SO; Mensah GI; Mosi L; Bonsu FA
    BMC Infect Dis; 2017 Dec; 17(1):743. PubMed ID: 29197331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing drug resistance of Mycobacterium tuberculosis isolates in a medical center in northern Taiwan.
    Su WJ; Feng JY; Huang CC; Perng RP
    J Formos Med Assoc; 2008 Mar; 107(3):259-64. PubMed ID: 18400612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.